Clin Endocrinol:雌激素治疗可增加神经性厌食女孩BMD

2013-09-03 佚名 丁香园

神经性厌食(AN)的青少年是有闭经,并且有骨量增长减少和低骨矿密度(BMD)。间充质干细胞分化调节是一种调节骨形成的重要因素。前脂肪细胞因子1(Pref-1),一种脂肪细胞和成骨细胞分化的抑制剂,在雌激素缺乏状态下升高。为了探讨AN的青春期女孩雌二醇经皮给药对Pref-1的影响,并检测Pref-1变化与腰椎BMD和骨转换标志物变化之间的关系,来自美国哈佛大学医学院的Anne

神经性厌食(AN)的青少年是有闭经,并且有骨量增长减少和低骨矿密度(BMD)。间充质干细胞分化调节是一种调节骨形成的重要因素。前脂肪细胞因子1(Pref-1),一种脂肪细胞和成骨细胞分化的抑制剂,在雌激素缺乏状态下升高。为了探讨AN的青春期女孩雌二醇经皮给药对Pref-1的影响,并检测Pref-1变化与腰椎BMD和骨转换标志物变化之间的关系,来自美国哈佛大学医学院的Anne Klibanski教授及其团队进行了一项研究,该研究发现AN青春期女孩使用雌激素后Pref-1下调。AN女孩Pref-1的抑制可能由雌二醇经皮替代治疗对BMD的有益影响介导。该研究结果发表在2013年9月的Clinical Endocrinology杂志上。【原文下载

该研究中,横断面研究AN青春期女孩和正常体重对照者。在一项双盲研究中,接受雌二醇经皮给药(加用周期性甲羟孕酮)或安慰剂治疗12个月,纵向调查AN女孩。在基线研究69例13-18岁女孩(44例为AN,25例为正常体重对照者),22例AN女孩之后进行前瞻性研究。测量Pref-1水平、骨形成和骨吸收标志物和BMD.该研究结果表明,尽管在基线时,AN女孩与对照组相比,Pref-1水平没有差别,与安慰剂组相比,雌二醇经皮给药组治疗后AN女孩Pref-1水平下降。12个月期间Pref-1的变化与腰椎BMD变化呈负相关,而与CTX变化呈正相关。

该研究发现,AN青春期女孩使用雌激素后Pref-1下调。AN女孩Pref-1的抑制可能由雌二醇经皮替代治疗对BMD的有益影响介导。

原文下载:

Faje AT, Fazeli PK, Katzman D, Miller KK, Breggia A, Rosen CJ, Mendes N, Misra M, Klibanski A. Inhibition of Pref-1 (preadipocyte factor 1) by oestradiol in adolescent girls with anorexia nervosa is associated with improvement in lumbar bone mineral density.Clin Endocrinol (Oxf). 2013 Sep;79(3):326-32. doi: 10.1111/cen.12144. Epub 2013 Jul 2.

版权声明:
本网站所有内容来源注明为“williamhill asia 医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于williamhill asia 医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“williamhill asia 医学”。其它来源的文章系转载文章,或“williamhill asia 号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与williamhill asia 联系,williamhill asia 将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1818988, encodeId=fc171818988e3, content=<a href='/topic/show?id=219e98e7065' target=_blank style='color:#2F92EE;'>#雌激素治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98770, encryptionId=219e98e7065, topicName=雌激素治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Mon Apr 21 23:06:00 CST 2014, time=2014-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2049666, encodeId=d97f20496660f, content=<a href='/topic/show?id=257ae42978d' target=_blank style='color:#2F92EE;'>#神经性厌食#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74297, encryptionId=257ae42978d, topicName=神经性厌食)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Mon Dec 30 10:06:00 CST 2013, time=2013-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035394, encodeId=1661203539400, content=<a href='/topic/show?id=d382e42956d' target=_blank style='color:#2F92EE;'>#神经性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74295, encryptionId=d382e42956d, topicName=神经性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=927d310, createdName=hywen7326, createdTime=Mon Aug 04 03:06:00 CST 2014, time=2014-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1307333, encodeId=2b44130e3337c, content=<a href='/topic/show?id=b1d766836e4' target=_blank style='color:#2F92EE;'>#激素治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66836, encryptionId=b1d766836e4, topicName=激素治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfa6343, createdName=aliceclz, createdTime=Thu Sep 05 05:06:00 CST 2013, time=2013-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605329, encodeId=0e601605329d2, content=<a href='/topic/show?id=66273555cc' target=_blank style='color:#2F92EE;'>#BMD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3555, encryptionId=66273555cc, topicName=BMD)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2a219374906, createdName=1249859em44(暂无昵称), createdTime=Thu Sep 05 05:06:00 CST 2013, time=2013-09-05, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1818988, encodeId=fc171818988e3, content=<a href='/topic/show?id=219e98e7065' target=_blank style='color:#2F92EE;'>#雌激素治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98770, encryptionId=219e98e7065, topicName=雌激素治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Mon Apr 21 23:06:00 CST 2014, time=2014-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2049666, encodeId=d97f20496660f, content=<a href='/topic/show?id=257ae42978d' target=_blank style='color:#2F92EE;'>#神经性厌食#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74297, encryptionId=257ae42978d, topicName=神经性厌食)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Mon Dec 30 10:06:00 CST 2013, time=2013-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035394, encodeId=1661203539400, content=<a href='/topic/show?id=d382e42956d' target=_blank style='color:#2F92EE;'>#神经性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74295, encryptionId=d382e42956d, topicName=神经性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=927d310, createdName=hywen7326, createdTime=Mon Aug 04 03:06:00 CST 2014, time=2014-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1307333, encodeId=2b44130e3337c, content=<a href='/topic/show?id=b1d766836e4' target=_blank style='color:#2F92EE;'>#激素治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66836, encryptionId=b1d766836e4, topicName=激素治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfa6343, createdName=aliceclz, createdTime=Thu Sep 05 05:06:00 CST 2013, time=2013-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605329, encodeId=0e601605329d2, content=<a href='/topic/show?id=66273555cc' target=_blank style='color:#2F92EE;'>#BMD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3555, encryptionId=66273555cc, topicName=BMD)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2a219374906, createdName=1249859em44(暂无昵称), createdTime=Thu Sep 05 05:06:00 CST 2013, time=2013-09-05, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1818988, encodeId=fc171818988e3, content=<a href='/topic/show?id=219e98e7065' target=_blank style='color:#2F92EE;'>#雌激素治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98770, encryptionId=219e98e7065, topicName=雌激素治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Mon Apr 21 23:06:00 CST 2014, time=2014-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2049666, encodeId=d97f20496660f, content=<a href='/topic/show?id=257ae42978d' target=_blank style='color:#2F92EE;'>#神经性厌食#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74297, encryptionId=257ae42978d, topicName=神经性厌食)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Mon Dec 30 10:06:00 CST 2013, time=2013-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035394, encodeId=1661203539400, content=<a href='/topic/show?id=d382e42956d' target=_blank style='color:#2F92EE;'>#神经性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74295, encryptionId=d382e42956d, topicName=神经性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=927d310, createdName=hywen7326, createdTime=Mon Aug 04 03:06:00 CST 2014, time=2014-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1307333, encodeId=2b44130e3337c, content=<a href='/topic/show?id=b1d766836e4' target=_blank style='color:#2F92EE;'>#激素治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66836, encryptionId=b1d766836e4, topicName=激素治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfa6343, createdName=aliceclz, createdTime=Thu Sep 05 05:06:00 CST 2013, time=2013-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605329, encodeId=0e601605329d2, content=<a href='/topic/show?id=66273555cc' target=_blank style='color:#2F92EE;'>#BMD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3555, encryptionId=66273555cc, topicName=BMD)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2a219374906, createdName=1249859em44(暂无昵称), createdTime=Thu Sep 05 05:06:00 CST 2013, time=2013-09-05, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1818988, encodeId=fc171818988e3, content=<a href='/topic/show?id=219e98e7065' target=_blank style='color:#2F92EE;'>#雌激素治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98770, encryptionId=219e98e7065, topicName=雌激素治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Mon Apr 21 23:06:00 CST 2014, time=2014-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2049666, encodeId=d97f20496660f, content=<a href='/topic/show?id=257ae42978d' target=_blank style='color:#2F92EE;'>#神经性厌食#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74297, encryptionId=257ae42978d, topicName=神经性厌食)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Mon Dec 30 10:06:00 CST 2013, time=2013-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035394, encodeId=1661203539400, content=<a href='/topic/show?id=d382e42956d' target=_blank style='color:#2F92EE;'>#神经性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74295, encryptionId=d382e42956d, topicName=神经性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=927d310, createdName=hywen7326, createdTime=Mon Aug 04 03:06:00 CST 2014, time=2014-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1307333, encodeId=2b44130e3337c, content=<a href='/topic/show?id=b1d766836e4' target=_blank style='color:#2F92EE;'>#激素治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66836, encryptionId=b1d766836e4, topicName=激素治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfa6343, createdName=aliceclz, createdTime=Thu Sep 05 05:06:00 CST 2013, time=2013-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605329, encodeId=0e601605329d2, content=<a href='/topic/show?id=66273555cc' target=_blank style='color:#2F92EE;'>#BMD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3555, encryptionId=66273555cc, topicName=BMD)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2a219374906, createdName=1249859em44(暂无昵称), createdTime=Thu Sep 05 05:06:00 CST 2013, time=2013-09-05, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1818988, encodeId=fc171818988e3, content=<a href='/topic/show?id=219e98e7065' target=_blank style='color:#2F92EE;'>#雌激素治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98770, encryptionId=219e98e7065, topicName=雌激素治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Mon Apr 21 23:06:00 CST 2014, time=2014-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2049666, encodeId=d97f20496660f, content=<a href='/topic/show?id=257ae42978d' target=_blank style='color:#2F92EE;'>#神经性厌食#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74297, encryptionId=257ae42978d, topicName=神经性厌食)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Mon Dec 30 10:06:00 CST 2013, time=2013-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035394, encodeId=1661203539400, content=<a href='/topic/show?id=d382e42956d' target=_blank style='color:#2F92EE;'>#神经性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74295, encryptionId=d382e42956d, topicName=神经性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=927d310, createdName=hywen7326, createdTime=Mon Aug 04 03:06:00 CST 2014, time=2014-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1307333, encodeId=2b44130e3337c, content=<a href='/topic/show?id=b1d766836e4' target=_blank style='color:#2F92EE;'>#激素治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66836, encryptionId=b1d766836e4, topicName=激素治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfa6343, createdName=aliceclz, createdTime=Thu Sep 05 05:06:00 CST 2013, time=2013-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605329, encodeId=0e601605329d2, content=<a href='/topic/show?id=66273555cc' target=_blank style='color:#2F92EE;'>#BMD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3555, encryptionId=66273555cc, topicName=BMD)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2a219374906, createdName=1249859em44(暂无昵称), createdTime=Thu Sep 05 05:06:00 CST 2013, time=2013-09-05, status=1, ipAttribution=)]

相关威廉亚洲官网

JNCI:雌激素联合黄体酮会增高乳腺癌发病率

两组患者确诊后的生存时间 在妇女健康倡议(WHI)随机研究中,研究者发现雌激素联合黄体酮会增加女性乳腺癌发病率和死亡率。与之相反,绝大多数和雌激素联合黄体酮有关的观察性研究都指出这些乳腺癌患者的预后尚可。为了对上述问题进行进一步探讨,来自加利福尼亚州UCLA医学中心的Rowan T. Chlebowski等选择了与WHI临床研究中受试者具有相同特征的受试者组成了WHI观察性研究的受试者,并探讨了

PLoS Biology:研究发现转录因子可导致乳腺癌对抗雌激素治疗无应答

  澳大利亚的科学家们已经证实一种“转录因子”如何引起乳腺癌进展为侵袭性亚型,而且这种亚型缺乏对雌激素的敏感性,同时对于像他莫昔芬和芳香酶抑制剂这样的抗雌激素药物治疗无效。   转录因子是一类可以转换基因的“开”或“关”的分子。在这种情况下,所熟知的转录因子“ELF5”在乳腺癌细胞的极早期抑制其对雌激素的敏感性。2008年,来自悉尼Garvan医学研究所的副教授Chris Orma

CEBP:多运动可降患乳腺癌风险

  据新华社消息美国一项临床研究显示,体育运动改变雌激素新陈代谢的方式,因而可降低罹患乳腺癌的风险。这是首项解释运动预防乳腺癌背后机制的临床研究。   运动需要达到一定强度   明尼苏达大学食品科学学院的明迪·库尔策教授主持这项名为“女性稳定运动研究”的临床研究。研究人员征募391名身体健康、习惯久坐的绝经前女性,根据年龄和身高体重指数(BMI)把她们分成两组:212人组成干预组,179人为对

Lancet Oncoloy:绝经后女性子宫切除术后短期补充雌激素不会增加患乳腺癌风险

     近期,美国西雅图弗雷德?哈钦森癌症研究中心公共卫生学部的Garnet L. Anderson博士等在《柳叶刀?肿瘤学》(Lancet Oncology 2012, 13: 476-486)发表论文指出,在接受子宫切除术的绝经后女性中,使用雌激素约5年的患者并发乳腺癌的风险降低了23%,归因于乳腺癌的死亡风险降低了63%。  

Sci. Transl. Med.:雌激素可在绝经后妇女中抵御UTIs

据一项新的研究报告,在绝经后妇女中,雌激素可帮助保护其尿路免受感染。 这些发现可帮助解释为什么雌激素补充剂可在绝经后妇女中抵御感染复发。尿路感染或UTIs是妇女看医生的最常见原因之一——有多达60%的妇女至少会发生一次UTI,有25%的妇女有过反复的尿路感染。 Petra Lüthje及其同事如今显示,雌激素可增加身体自制的被称作抗菌肽的抗生素的产生。研究人员给一组绝经后妇女为期2周的雌激素补

雌激素有助抵御尿路感染

一项新研究称,在绝经后妇女中,雌激素可帮助保护其尿路免受感染。这些发现有助解释为什么雌激素补充剂可在绝经后妇女中抵御感染复发。 有多达60%的妇女至少会发生一次尿路感染,有25%的妇女有过反复的尿路感染。 Petra Lthje及其同事发现,雌激素可增加身体自制的被称作抗菌肽的抗生素的产生。研究人员给一组绝经后妇女为期2周的雌激素补充剂,并进行了分析。他们发现,雌激素会作用于基因表达,以帮助激